Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

Objectives: To evaluate, in long-term open label prospective study, infliximab as therapeutic choice for Juvenile Idiopathic Arthritis (JIA) non responsive to conventional therapy. Methods: We enrolled to treat with infliximab 78 JIA patients (66 females, 12 males): the mean age was 20.7±7.1 years (...

Full description

Bibliographic Details
Main Authors: M. Gattinara, E. Valcamonica, A. Salmaso, B. Teruzzi, A. Lurati, I. Pontikaki, V. Gerloni, G. De Marco, F. Fantini
Format: Article
Language:English
Published: PAGEPress Publications 2011-09-01
Series:Reumatismo
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/295

Internet

http://www.reumatismo.org/index.php/reuma/article/view/295

Similar Items